OR WAIT null SECS
Research Triangle Park, N.C.
Early phase drug development consulting firm ClinPharm Consulting and 20-year pharmaceutical industry veteran Eric Nelson, Ph.D. have announced a partnership to expand upon their offerings for emerging pharmaceutical and biotechnology companies.
Dr. Nelson's firm, NCE Biotech, and ClinPharm Consulting will collaborate to offer an integrated suite of clinical pharmacology, R&D strategy, and business development services, enabling the firms to provide strategic advice related to optimizing drug development programs. This new service enables clients to build the best efficacy/safety and market profiles for their drug development programs for discussions with pharmaceutical company partners and potential investors.
ClinPharm Consulting offers a full clinical pharmacology development package to clients and is a complete resource for virtual companies seeking to advance early phase drug development programs. According to Dr. Banks, early phase drug development needs to be coordinated with business development activities in order to most effectively translate early discussions with potential pharma partners into workable R&D development plans.
NCE Biotech's services include consulting to large pharmaceutical companies to help them divest drug programs; finding Asian investor funding for U.S. biotechnology companies and universities; working with private equity groups to acquire idle biotech assets; and running virtual drug development teams.
"The new partnership with ClinPharm Consulting is a great fit for our firm as the combined team can now provide cost-effective, integrated drug development and business development advice to our clients", said Dr. Nelson, managing partner at NCE Biotech.